Perspectives on the Regulatory and Clinical Science of Drug-Induced Liver Injury (DILI)-Reference-Cited by-同舟云学术

Perspectives on the Regulatory and Clinical Science of Drug-Induced Liver Injury (DILI)

Published:2018 Issue: Volume: Page:367-393
ISSN:1557-2153
Container-title:Methods in Pharmacology and Toxicology
language:
Short-container-title:

Author:

Avigan Mark I.,Muñoz Monica A.

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4939-7677-5_18

Reference101 articles.

1. Fontana RJ (2014) Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology 146(4):914–928. https://doi.org/10.1053/j.gastro.2013.12.032

2. Watkins PB, Kaplowitz N, Slattery JT, Colonese CR, Colucci SV, Stewart PW, Harris SC (2006) Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 296(1):87–93. https://doi.org/10.1001/jama.296.1.87

3. Avigan MI (2013) Regulatory perspectives. In: Kaplowitz N, Deleve LD (eds) Drug-induced liver disease, 3rd edn. Academic Press, London, UK, pp 689–712

4. Enhancing Benefit-Risk Assessment in Regulatory Decision-Making. Available: https://www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm326192.htm . Accessed 18 Mar 2017

5. Hepatotoxicity (textbook) first edition (1978) Zimmerman Chapter 16, p 349–369

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Escitalopram-induced hepatitis: A case report;World Journal of Clinical Cases;2022-03-16

2. Diverse approaches to predicting drug-induced liver injury using gene-expression profiles;Biology Direct;2020-01-15

3. Drug-induced liver injury;Nature Reviews Disease Primers;2019-08-22

4. Predicting the Risks of Drug-Induced Liver Injury in Humans Utilizing Computational Modeling;Challenges and Advances in Computational Chemistry and Physics;2019